Skip to content
  1. Home/
  2. Latest news/
  3. Caring & giving/
  4. 9 ways Johnson & Johnson is sharing its vision for good with the world
People given cataract surgeries by Himalayan Cataract Project, an organization devoted to eliminating preventable and curable blindness

9 ways Johnson & Johnson is sharing its vision for good with the world

For World Sight Day, we share stats about how the company is helping expand eye care across the globe through advocacy, education and sustainable innovation.

More than 1 billion people around the world are living with vision impairment because they don’t have access to eye care or treatment.

It’s a fact that Johnson & Johnson Vision is determined to help change, and one that’s even more apparent now that the COVID-19 pandemic has shined a spotlight on the health disparities that exist across the globe: According to the World Health Organization, the burden of eye conditions and vision impairment is far greater in people such as those with low incomes, ethnic minorities and indigenous populations.

Through partnerships and scientific innovation, Johnson & Johnson Vision is aiming to tackle these health hurdles while also focusing on ensuring a healthier planet for generations to come, by reducing its carbon footprint, limiting landfill contribution and protecting natural resources. Recently, for example, Johnson & Johnson Vision signed a 10-year power purchase agreement with a solar farm to cover 100% of the electricity consumption of its headquarters in Jacksonville, Florida.

Here, key highlights from the Johnson & Johnson Vision 2020 impact report, Vision for Good, which launched this month and details the strides the company has already made toward these goals.


vc-infographic-final-0602.png

Read the 2020 Johnson & Johnson Vision Impact Report

Access the full report to learn more about how the company is working to improve vision around the world.

More from Johnson & Johnson

Inside Johnson & Johnson’s decades-long quest to develop effective treatments for IBD

Inflammatory bowel disease doesn’t have a cure—yet. But the recent FDA approval of a promising medication is the latest in a long line of treatments from Johnson & Johnson that are helping patients with IBD.

The future of immunology

Learn about the advances Johnson & Johnson is making to potentially help treat the millions of people living with conditions in which the immune system mistakenly damages healthy cells in the body.

5 things we now know about colorectal cancer

Surprising new research suggests that people younger than 50 are getting diagnosed with the disease at record rates. For National Colorectal Cancer Awareness Month, find out how to protect yourself—no matter your age.